January 27, 2023 — Fujifilm has completed its asset purchase of Inspirata, Inc.’s digital pathology business effective January 23, 2023. The Dynamyx digital pathology technology and U.S. employees who supported that business, including all Dynamyx product development, are now part of FUJIFILM Healthcare Americas Corporation.
To deliver on the significant demand and market growth potential of the digital pathology market, Fujifilm has also established a pathology division of its Medical Informatics business. This new pathology division is led by Dr. Mark Lloyd, business leader and head scientist of the Dynamyx product. Mark brings more than 20 years of pathology experience to the organization.
“Transforming and improving the diagnostic experience for patients and care teams has been the force driving my life's work,” says Dr. Mark Lloyd, vice president, pathology, FUJIFILM Healthcare Americas Corporation. “After a few years of successful partnership, I'm thrilled for my team and I to take the next step and officially join Fujifilm – an organization who shares in our vision and has the breadth, depth and resources required to take our Dynamyx platform to the next stage of its growth and international expansion.”
The creation of a digital pathology division expands Fujifilm’s robust Synapse® Enterprise Imaging offering to enable the digitization and integration of pathology images and data into a healthcare organization’s electronic health record system and to help streamline care delivery for oncology patients and provider teams.
“We are in the very early stages of digital pathology adoption in the healthcare market, much like the radiology PACS market when we first introduced Synapse. We are very excited to expand our award-winning enterprise imaging portfolio with digital pathology, and once again demonstrate our ability to innovate in a new area of imaging informatics,” says Bill Lacy, senior vice president, medical informatics, FUJIFILM Healthcare Americas Corporation. “We’re proud and grateful to begin 2023 welcoming Inspirata’s digital pathology team to our organization - they bring with them years of passion, established trust in the industry, and the expertise necessary for our digital pathology business and customers to thrive.”
Dynamyx is an open, vendor-agnostic, end-to-end digital pathology solution. Dynamyx’s software capabilities include using whole slide images from multiple scanning vendors to create an easier path for more pathology labs to digitize and realize the benefits of faster patient results, centralized imaging records, and enterprise access to images for all clinicians. It is installed in medical facilities that handle large volumes of pathological images across multiple lab locations, allowing the use of their preferred mix of laboratory and diagnostic technologies with confidence of full compatibility.
Dynamyx became part of Fujifilm’s Synapse Enterprise Imaging portfolio – an award-winning suite of healthcare IT solutions that unify imaging, data access and workflows across the health system – on January 23rd. The integrated technologies will be demonstrated at the 112th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP) in New Orleans held March 11-16, and the 2023 Healthcare Information and Management Systems Society (HIMSS) annual meeting in Chicago held April 17-21. Those interested in learning more can contact Fujifilm here.
March 26, 2026 
